{"id":"W3190141894","doi":"10.1016/s1470-2045(21)00376-4","title":"Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":277,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Centre for Mathematical Cognition, Loughborough University; Pfizer UK; Pfizer","keywords":"Medicine; Prostate cancer; Enzalutamide; Oncology; Internal medicine; PARP inhibitor; Clinical endpoint; Docetaxel; Cancer; Clinical trial; Poly ADP ribose polymerase; Androgen receptor; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006688249,0.0001770646,0.0006237661,0.00006892695,0.0001852051,0.00008682613,0.0001932636,0.00005677312,0.0002898177],"category_scores_gemma":[0.00004592827,0.0001039362,0.0000295056,0.0004324494,0.0001844921,0.000216999,0.00005555273,0.0003160166,0.000008283193],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003791163,"about_ca_system_score_gemma":0.002484071,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005419428,"about_ca_topic_score_gemma":0.008999149,"domain_scores_codex":[0.9980649,0.0005065115,0.0003510717,0.0004045079,0.0002343736,0.0004386066],"domain_scores_gemma":[0.9989033,0.0001400327,0.0001185657,0.0005245946,0.0001886123,0.0001249293],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7454408,0.01736321,0.002992389,0.0002515388,0.001550671,0.006111213,0.009420419,0.0002086392,0.173393,0.004003013,0.007933412,0.03133166],"study_design_scores_gemma":[0.8671752,0.03556387,0.003326947,0.0002479265,0.0004976324,0.0003069771,0.001880718,0.002474977,0.02129298,0.001268512,0.06549625,0.0004680229],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9752885,0.001232595,0.00001804564,0.01857285,0.0001618762,0.002859497,0.0001238136,0.0000585344,0.00168431],"genre_scores_gemma":[0.9829203,0.001601116,0.003784012,0.002163704,0.0005858861,0.003170527,0.0004989535,0.00005123485,0.005224244],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1521,"threshold_uncertainty_score":0.5021737,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1727428949262219,"score_gpt":0.4787019484634764,"score_spread":0.3059590535372544,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}